News.
Stay up to date with the latest news about our innovation initiatives
Published on 09/02/2024
Looking for new therapeutic approaches for AD
Almirall and CRG collaborate to identify molecular pathways and biomarkers specific to atopic dermatitis.
Almirall, Barcelona Supercomputing Center (BSC) and Nostrum Biodiscovery collaborate to design new protein-protein modulators through Artificial Intelligence.
We are looking for collaboration opportunites focused on pathological mechanisms common across different organs and tissues that can be translatable to skin diseases
Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer
We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.
